(Q51919175)

17 April 2018

title

Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells. (English)

1 reference

17 April 2018

1 reference

2

Sagar Lonial

1 reference

17 April 2018

Michelle L Hicks

1

1 reference

17 April 2018

Amelia Langston

3

1 reference

17 April 2018

Christopher Flowers

4

1 reference

17 April 2018

John D Roback

5

1 reference

17 April 2018

Kenneth J Smith

6

1 reference

17 April 2018

Sarah Mossavi Sai

7

1 reference

17 April 2018

Diane Teagarden

8

1 reference

17 April 2018

Ellie S Hamilton

9

1 reference

17 April 2018

Edmund K Waller

10

1 reference

17 April 2018

Jonathan Kaufman

11

1 reference

17 April 2018

publication date

1 April 2007

1 reference

17 April 2018

published in

Transfusion

1 reference

17 April 2018

volume

47

1 reference

17 April 2018

issue

4

1 reference

17 April 2018

page(s)

629-635

1 reference

17 April 2018

An evaluation of predictive factors for CD34+ cell harvest yields from patients mobilized with chemotherapy and growth factors

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01164.X

Accurate calculation of blood volume to be processed by apheresis to achieve target CD34+ cell numbers for PBPC transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01164.X

Using point-of-care CD34 enumeration to optimize PBSC collection conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01164.X

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01164.X

The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01164.X

Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01164.X

DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01164.X

The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2007.01164.X

10.1111/J.1537-2995.2007.01164.X

21 January 2018

Identifiers

DOI

1 reference

17 April 2018

PubMed ID

17381621

1 reference

17 April 2018